VIA
AVEO

Virtus Investment Advisers’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Virtus Investment Advisers’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,362
Closed -$140K – 353
2022
Q4 		$140K Sell
9,362
-3,312
-26% -$45.9K 0.09% 238
2022
Q3 		$104K Buy
+12,674
New +$97.3K 0.05% 290

Virtus Investment Advisers's AVEO Position: Q1 2023 in Review

Virtus Investment Advisers sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 9,362 shares — an estimated $140K sold.

Virtus Investment Advisers first reported a position in AVEO in Q3 2022 and held it in 2 quarters. The position peaked at $140K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Virtus Investment Advisers reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Virtus Investment Advisers sold 9,362 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $140K.
  • Virtus Investment Advisers first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2022 and held it in 2 quarters.
  • Virtus Investment Advisers's AVEO Pharmaceuticals, Inc. position peaked at $140K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Virtus Investment Advisers's 13F filing for Q1 2023, filed 15 May 2023.